Castle Biosciences: Q4 Earnings Insights

Castle Biosciences CSTL reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Castle Biosciences beat estimated earnings by 46.81%, reporting an EPS of $-0.25 versus an estimate of $-0.47.

Revenue was up $7.74 million from the same period last year.

Last quarter the company missed on EPS by $0.07 which was followed by a 10.19% drop in the share price the next day.

Here's a look at Castle Biosciences's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.40	-0.37	-0.24	-0.12
EPS Actual	-0.47	-0.34	-0.17	-0.17
Revenue Estimate	22.97M	18.93M	16.66M	15.74M
Revenue Actual	23.48M	22.76M	22.81M	17.30M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar